Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock.

ABSTRACT:

Background

Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in AMICS patients stratified according to the Society of Cardiovascular Angiography and Interventions (SCAI) shock classification.

Methods

Retrospective analysis of patients with AMICS admitted to cardiac intensive care unit at two tertiary cardiac centers during 2010-2017 with retrieval of real-time hemodynamic data and dosages of vasoactive drugs from intensive care unit databases.

Results

Out of 1,249 AMICS patients classified into SCAI class C, D, and E, mortality increased for each shock stage from 34% to 60%, and

SUBMITTER: Udesen NLJ 

PROVIDER: S-EPMC9352108 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature